DAWN DRURY: Open Payments
NPI 1467015560 · CALIFORNIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,872 in 63 payments from 37 companies in 2025. Trend: 2023 $1,107 · 2024 $1,521 · 2025 $1,872
Food & beverage: $1,573Education: $299
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $241 |
| Eisai Inc. | 4 | $164 |
| Janssen Biotech, Inc. | 6 | $151 |
| SEAGEN INC. | 1 | $100 |
| Gilead Sciences, Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Exact Sciences Corporation | 1 | $80 |
| EMD Serono, Inc. | 3 | $66 |
| TAIHO ONCOLOGY, INC. | 2 | $59 |
| Exelixis Inc. | 2 | $59 |
Products named: Lenvima, Enhertu, Trodelvy, Cologuard Collection Kit, CARVYKTI, INJECTAFER, ERLEADA, LONSURF.
Industry payments across MD — which companies pay providers there.
